DiaMedica Therapeutics Inc.
DMAC
$5.42
-$0.19-3.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.76% | -3.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.77% | 1.99% | |||
| Operating Income | -13.77% | -1.99% | |||
| Income Before Tax | -14.95% | -1.35% | |||
| Income Tax Expenses | -30.00% | 66.67% | |||
| Earnings from Continuing Operations | -14.90% | -1.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.90% | -1.39% | |||
| EBIT | -13.77% | -1.99% | |||
| EBITDA | -13.79% | -2.07% | |||
| EPS Basic | -12.00% | 4.03% | |||
| Normalized Basic EPS | -12.01% | 4.06% | |||
| EPS Diluted | -12.00% | 4.03% | |||
| Normalized Diluted EPS | -12.01% | 4.06% | |||
| Average Basic Shares Outstanding | 2.63% | 5.62% | |||
| Average Diluted Shares Outstanding | 2.63% | 5.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||